Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease
The Egyptian Heart Journal · 2011
DOI: 10.1016/j.ehj.2011.08.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Heart Journal, 2011. Verfasst von Nader El-Shahhat und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
El-Shahhat, N., Ramadan, M. M., El-Malkey, N., Omar, A. A., El-Aal, I. A. A., & Eneen, A. (2011). Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease. The Egyptian Heart Journal. https://doi.org/10.1016/j.ehj.2011.08.024
Vancouver
El-Shahhat N, Ramadan MM, El-Malkey N, Omar AA, El-Aal IAA, Eneen A. Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease. The Egyptian Heart Journal. 2011. doi:10.1016/j.ehj.2011.08.024
BibTeX
@article{ElShahhat2011,
author = {El-Shahhat, Nader and Ramadan, Mahmoud M. and El-Malkey, Nader and Omar, Ashraf A. and El-Aal, Ibrahim A. Abd and Eneen, Asmaa},
title = {Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease},
journal = {The Egyptian Heart Journal},
year = {2011},
doi = {10.1016/j.ehj.2011.08.024}
}
EUVIMED